PUBLISHER: The Business Research Company | PRODUCT CODE: 1810836
PUBLISHER: The Business Research Company | PRODUCT CODE: 1810836
Bioabsorbable surgical mesh is a medical implant crafted from materials that gradually degrade and are absorbed by the body, providing temporary support to tissues during the healing process. These meshes are commonly used in surgeries like hernia repair and soft tissue reinforcement, helping to avoid permanent implants and reducing the risk of long-term complications.
The main categories of bioabsorbable surgical mesh include polymer-based mesh, composite mesh, and bioactive mesh. Polymer-based mesh consists of synthetic polymers such as polyglycolic acid (PGA), polylactic acid (PLA), or their copolymers. Materials used include polylactic acid, polyglycolic acid, polycaprolactone, composite materials, and natural polymers. These products are distributed through channels like direct sales, online platforms, distributors, and wholesalers. They find applications in hernia repair, dural repair, urological surgery, cardiovascular surgery, orthopedic surgery, and more, serving end users such as hospitals, ambulatory surgical centers, specialty clinics, and research institutions.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.
The bioabsorbable surgical mesh market research report is one of a series of new reports from The Business Research Company that provides bioabsorbable surgical mesh market statistics, including bioabsorbable surgical mesh industry global market size, regional shares, competitors with a bioabsorbable surgical mesh market share, bioabsorbable surgical mesh market segments, market trends and opportunities, and any further data you may need to thrive in the bioabsorbable surgical mesh industry. This bioabsorbable surgical mesh market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bioabsorbable surgical mesh market size has grown strongly in recent years. It will grow from $1.14 billion in 2024 to $1.25 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth during the historic period can be attributed to the rising prevalence of chronic diseases, an increase in surgical procedures, a growing elderly population, greater adoption of minimally invasive surgeries, and improvements in healthcare infrastructure.
The bioabsorbable surgical mesh market size is expected to see strong growth in the next few years. It will grow to $1.73 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The anticipated growth in the forecast period can be attributed to rising healthcare spending, increased awareness of advanced surgical options, growing preference for absorbable mesh, more regulatory approvals, and expanding demand in emerging markets. Key trends expected include advancements in bioabsorbable materials, integration with minimally invasive techniques, technology-driven product innovations, improvements in mesh biocompatibility, and the development of customized absorption rates.
The increasing number of surgical procedures is expected to drive the growth of the bioabsorbable surgical mesh market in the coming years. Surgical procedures involve medical interventions that intentionally alter body structures, usually by cutting or repairing tissue, to treat, diagnose, or prevent diseases, injuries, or other conditions. The rise in surgical procedures is mainly due to the growing prevalence of chronic diseases such as cardiovascular diseases, cancer, and obesity-related disorders. Bioabsorbable surgical mesh supports these procedures by providing temporary reinforcement to healing tissues and gradually dissolving, which lowers the risk of long-term complications related to permanent implants. For example, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a US-based organization for board-certified aesthetic plastic surgeons, reported a 5.5% increase in surgical procedures in 2023, with over 15.8 million surgeries and 19.1 million non-surgical procedures performed worldwide. Therefore, the growing volume of surgical procedures is fueling the expansion of the bioabsorbable surgical mesh market.
Key players in the bioabsorbable surgical mesh market are concentrating on creating advanced products like fully bioabsorbable pocket and strap designs to improve ease of placement and fixation during hernia repair surgeries. These designs incorporate absorbable structural components within the mesh, enabling accurate positioning and lateral fixation without the need for permanent implants. For instance, in April 2025, Becton, Dickinson and Company, a US-based medical device firm, introduced the Phasix ST Umbilical Hernia Patch. This is the first fully absorbable hernia patch specifically made for umbilical hernias, featuring a pocket and strap configuration made from poly-4-hydroxybutyrate (P4HB), a biologically derived polymer. The design mimics the handling and placement of permanent mesh but is entirely absorbed by the body over time. The patch also contains a hydrogel barrier using Sepra Technology to reduce tissue adhesion. Available in various sizes, it addresses a wide range of umbilical hernia defects and meets growing demand for non-permanent, patient-focused solutions in soft tissue reconstruction.
In December 2022, Integra LifeSciences Holdings Corporation, a US-based company, acquired Surgical Innovation Associates for an undisclosed sum. This acquisition aims to bolster Integra LifeSciences' position in the surgical reconstruction market and broaden its portfolio with advanced bioabsorbable mesh solutions designed for plastic and reconstructive surgery. Surgical Innovation Associates is a US-based medical device company specializing in bioabsorbable surgical mesh.
Major players in the bioabsorbable surgical mesh market are Johnson & Johnson, Medtronic plc, Becton, Dickinson and Company, Baxter International Inc., Integra LifeSciences Holdings Corporation, B. Braun Melsungen AG, Advanced Medical Solutions Group plc, TELA Bio Inc., Kerecis Limited, W. L. Gore & Associates Inc., Assut Europe S.p.A., BioHealth Medical Technology Co Ltd., Aroa Biosurgery Limited, Cook Biotech Incorporated, Tissue Regenix Group plc, Aran Biomedical Teoranta, Deep Blue Medical Advances Inc., Meccellis Biotech, PrintBio Inc., and Atrium Medical Corporation.
North America was the largest region in the bioabsorbable surgical mesh market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in bioabsorbable surgical mesh report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the bioabsorbable surgical mesh market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The bioabsorbable surgical mesh market consists of sales of collagen-based meshes, polyglycolic acid (PGA) meshes, polylactic acid (PLA) meshes, polycaprolactone (PCL) meshes, and composite bioabsorbable meshes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bioabsorbable Surgical Mesh Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on bioabsorbable surgical mesh market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for bioabsorbable surgical mesh ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioabsorbable surgical mesh market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.